Resources Contact Us Home
Methods of evaluating viral entry inhibitors using patient derived envelope protein constructs

Image Number 16 for United States Patent #7169551.

The invention provides a method for identifying whether a compound inhibits entry of a virus into a cell which comprises: (a) obtaining nucleic acid encoding a viral envelope protein from a patient infected by the virus; (b) co-transfecting into a first cell (i) the nucleic acid of step (a), and (ii) a viral expression vector which lacks a nucleic acid encoding an envelope protein, and which comprises an indicator nucleic acid which produces a detectable signal, such that the first cell produces viral particles comprising the envelope protein encoded by the nucleic acid obtained from the patient; (c) contacting the viral particles produced in step (b) with a second cell in the presence of the compound, wherein the second cell expresses a cell surface receptor to which the virus binds; (d) measuring the amount of signal produced by the second cell in order to determine the infectivity of the viral particles; and (e) comparing the amount of signal measured in step (d) with the amount of signal produced in the absence of the compound, wherein a reduced amount of signal measured in the presence of the compound indicates that the compound inhibits entry of the virus into the second cell.

  Recently Added Patents
Tracking data eye operating margin for steady state adaptation
RF amplifier with digital filter for polar transmitter
System for alarming upon occurrence of secession of smart key for vehicles
Clock face
Electrical connector
Valved, microwell cell-culture device and method
Preserving and handling native data in hybrid object trees
  Randomly Featured Patents
Method of manufacturing a display substrate
Bicycle rack
Circuit for electric power source
Apparatus for storing and moving a cassette
Measurement of flow velocity and mass flowrate
On-line help method and system utilizing free text query
Apparatus and method to access bone marrow
Rail controller mounting apparatus
Clear impact resistant thermoplastic star-block copolymers
Combination therapy using immunotoxins with interleukin-2